Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.

Glycoprotein 330 (gp330) is an endocytic receptor expressed in the renal proximal tubules and some other absorptive epithelia, e.g., in the inner ear. The present study shows that the antifibrinolytic polypeptide, aprotinin, and the nephro- and ototoxic antibiotics, aminoglycosides, and polymyxin B compete for binding of 125I-urokinase-plasminogen activator inhibitor type-1 complexes to purified rabbit gp330. Half maximal inhibition was measured at 4 microM for aprotinin, 50 microM for gentamicin, and 0.5 microM for polymyxin B. Drug binding to gp330 was validated by equilibrium dialysis of [3H] gentamicin-gp330 incubations and binding/uptake studies in rat proximal tubules and gp330-expressing L2 carcinoma cells. Analyses of mutant aprotinins expressed in Saccharomyces cerevisiae revealed that basic residues are essential for the binding to gp330 and renal uptake. The polybasic drugs also antagonized ligand binding to the human alpha 2-macroglobulin receptor. However, the rapid glomerular filtration of the drugs suggests kidney gp330 to be the quantitatively most important target. In conclusion, a novel role of gp330 as a drug receptor is demonstrated. The new insight into the mechanism of epithelial uptake of polybasic drugs might provide a basis for future design of drugs with reduced toxicity.

[1]  T. Hammond,et al.  Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules. , 1995, European journal of cell biology.

[2]  M. Farquhar,et al.  Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Moestrup,et al.  Binding and Endocytosis of Proteins Mediated by Epithelial gp330 , 1994, Annals of the New York Academy of Sciences.

[4]  A. Schwartz,et al.  The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Orth,et al.  Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein. , 1994, The Journal of biological chemistry.

[6]  J. Rastad,et al.  A protein involved in calcium sensing of the human parathyroid and placental cytotrophoblast cells belongs to the LDL-receptor protein superfamily. , 1994, Experimental cell research.

[7]  S. Moestrup.  The alpha 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands. , 1994, Biochimica et biophysica acta.

[8]  D. Strickland,et al.  Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissues. , 1994, In vivo.

[9]  I. Stamenkovic,et al.  Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  M. Krieger,et al.  Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). , 1994, Annual review of biochemistry.

[11]  S. Makker.  Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis. , 1993, Journal of immunology.

[12]  S. Moestrup,et al.  Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes. , 1993, The Journal of biological chemistry.

[13]  S. Moestrup,et al.  The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase. , 1993, The Journal of biological chemistry.

[14]  M. Waknitz,et al.  Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. , 1993, The Journal of biological chemistry.

[15]  S. Moestrup,et al.  Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats. , 1993, The Journal of biological chemistry.

[16]  W. Liao,et al.  Polymyxin B complexes with and cationizes low density lipoproteins. The cause of polymyxin B-induced enhancement of endocytotic catabolism of low density lipoproteins. , 1993, Biochemical pharmacology.

[17]  B. Molitoris,et al.  Mechanism of ischemia-enhanced aminoglycoside binding and uptake by proximal tubule cells. , 1993, The American journal of physiology.

[18]  M. Farquhar,et al.  Identification of a cell line that expresses a cell surface and a soluble form of the gp330/receptor-associated protein (RAP) Heymann nephritis antigenic complex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Brown,et al.  Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. , 1992, The Journal of biological chemistry.

[20]  D. Strickland,et al.  The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330. , 1992, The Journal of biological chemistry.

[21]  S. Moestrup,et al.  Renal tubule gp330 is a calcium binding receptor for endocytic uptake of protein. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  D. Kerjaschki,et al.  gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Moestrup,et al.  Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. , 1992, The Journal of biological chemistry.

[24]  D. Strickland,et al.  A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. , 1992, The Journal of biological chemistry.

[25]  W. Liao,et al.  Polymyxin B enhances low density lipoprotein catabolism in hepatic and extrahepatic cells. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  J. Kanalas,et al.  Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. , 1991, The Journal of biological chemistry.

[27]  J. Veldman,et al.  Ultrastructural localization of gentamicin in the cochlea , 1990, Hearing Research.

[28]  M. Costlow,et al.  Binding of polymyxin B to rat alveolar macrophages. , 1990, The Journal of infectious diseases.

[29]  S. Moestrup,et al.  The human alpha 2-macroglobulin receptor contains high affinity calcium binding sites important for receptor conformation and ligand recognition. , 1990, Journal of Biological Chemistry.

[30]  K. Norris,et al.  Aprotinin and aprotinin analogues expressed in yeast. , 1990, Biological chemistry Hoppe-Seyler.

[31]  R. Raychowdhury,et al.  Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. , 1989, Science.

[32]  J. Schacht,et al.  Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. , 1986, The Journal of clinical investigation.

[33]  W. Bennett,et al.  Chronic gentamicin nephrotoxicity. Continued tubular injury with preserved glomerular filtration function. , 1986, The American journal of pathology.

[34]  P. Verroust,et al.  Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. II. Extrarenal distribution. , 1986, The American journal of pathology.

[35]  J. Gliemann,et al.  Characterization of receptors for α2-macroglobulin-trypsin complex in rat hepatocytes , 1986 .

[36]  K. Kenyon,et al.  Retinal toxicity of intravitreal gentamicin. An electron microscopic study. , 1984, Investigative ophthalmology & visual science.

[37]  Ashutosh Kumar Singh,et al.  Characterization of the antigen (gp600) of Heymann nephritis. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[38]  J. Weinberg,et al.  Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity. , 1984, The Journal of clinical investigation.

[39]  H. Rennke,et al.  Renal tubular uptake of protein: effect of molecular charge. , 1983, The American journal of physiology.

[40]  V. Batuman,et al.  Transport of gentamicin in rat proximal tubule. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[41]  D. Kerjaschki,et al.  The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Weinberg,et al.  Identification of the aminoglycoside binding site in rat renal brush border membranes. , 1982, The Journal of pharmacology and experimental therapeutics.

[43]  C. Jacobsen,et al.  Determination of reserve albumin-equivalent for ligand binding, probing two distinct binding functions of the protein. , 1982, Analytical biochemistry.

[44]  H. Rennke,et al.  Effect of molecular charge on endocytic uptake of ferritin in renal proximal tubule cells. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[45]  P. Tulkens,et al.  Gentamicin-induced nephrotoxicity: a cell biology approach. , 1980, Kidney international.

[46]  F. van Leuven,et al.  Demonstration of an alpha2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. , 1979, The Journal of biological chemistry.

[47]  P. Tulkens,et al.  Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Quantitative ultrastructural and biochemical study. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[48]  F. Silverblatt,et al.  Autoradiography of gentamicin uptake by the rat proximal tubule cell. , 1979, Kidney international.

[49]  D. Morrison,et al.  Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. , 1976, Immunochemistry.

[50]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[51]  D. Houghton,et al.  A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. , 1976, The American journal of pathology.

[52]  T. Creighton,et al.  The two-disulphide intermediates and the folding pathway of reduced pancreatic trypsin inhibitor. , 1975, Journal of molecular biology.